Business description: Abcam plc

Number of employees: 1,760
Sales by Activity: Abcam plc
| Fiscal Period: December | 2019 (GBP) | 2020 (GBP) | 2021 (GBP) | 2022 (GBP) |
|---|---|---|---|---|
Sales of Antibodies and Related Products | 260M | 260M | 315M | 362M |
Geographical breakdown of sales: Abcam plc
| Fiscal Period: December | 2019 (GBP) | 2020 (GBP) | 2021 (GBP) | 2022 (GBP) |
|---|---|---|---|---|
The Americas | - | 112M | 130M | 162M |
EMEA | - | 69.3M | 84.3M | 90.1M |
China | 39.9M | 39.5M | 58.2M | 62.9M |
Rest of Asia | - | 20M | 23.8M | 28.3M |
Japan | 16.9M | 18.8M | 18.7M | 17.9M |
United Kingdom (UK) | 13.6M | - | - | - |
Other Countries | 58.7M | - | - | - |
Germany | 15.2M | - | - | - |
United States (US) | 116M | - | - | - |
Executive Committee: Abcam plc
| Manager | Title | Age | Since |
|---|---|---|---|
Alan Hirzel
CEO | Chief Executive Officer | 58 | 2014-09-08 |
Markus Lusser
PSD | President | 58 | 2024-03-17 |
Michael Baldock
DFI | Director of Finance/CFO | 62 | 2020-02-02 |
Tommy J. Thomas
IRC | Investor Relations Contact | - | 2022-06-26 |
Emma Sceats
SAM | Sales & Marketing | - | - |
Composition of the Board of Directors: Abcam plc
| Director | Title | Age | Since |
|---|---|---|---|
Alan Hirzel
BRD | Director/Board Member | 58 | 2013-12-31 |
Mara Aspinall
BRD | Director/Board Member | 63 | 2015-09-13 |
Giles Kerr
BRD | Director/Board Member | 67 | 2018-12-11 |
Michael Baldock
BRD | Director/Board Member | 62 | 2020-02-02 |
Luba Greenwood
BRD | Director/Board Member | 47 | 2022-09-11 |
Markus Lusser
BRD | Director/Board Member | 58 | 2025-07-28 |
Company details: Abcam plc

Biopharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.33% | +1.83% | +24.73% | -5.89% | 68.85B | ||
| +0.67% | +0.93% | +36.86% | +194.41% | 52.13B | ||
| +0.94% | +39.60% | +39.60% | +39.60% | 43.46B | ||
| +1.12% | +0.35% | -52.09% | -53.56% | 41.24B | ||
| -1.40% | +3.43% | +64.81% | -25.61% | 30.41B | ||
| -2.11% | -9.45% | +97.76% | -50.61% | 24.53B | ||
| +0.51% | +0.46% | +72.78% | +86.41% | 23.42B | ||
| -5.57% | -0.84% | -0.11% | +189.27% | 19.75B | ||
| -0.86% | -1.99% | +70.03% | +124.61% | 16.57B | ||
| Average | -0.78% | -0.66% | +39.37% | +55.40% | 35.6B | |
| Weighted average by Cap. | -0.34% | +0.10% | +32.55% | +46.97% |

















